View in EDS

Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort.

Saved in:
Bibliographic Details
Title: Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort.
Authors: Patel SP; UC San Diego Health Moores Cancer Center, La Jolla, California, USA spatel@ucsd.edu., Fisher J; University of Washington, Seattle, Washington, USA., Chae YK; Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Soto LS; Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kasi A; KUMC, Kansas City, Kansas, USA., Konda B; Internal Medicine, Division Of Medical Oncology, The Ohio State University, Columbus, Ohio, USA., Walshauser M; Cancer Care Center of O'Fallon, O'Fallon, Illinois, USA., Parra E; Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zhang J; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Hosuton, Texas, USA., Duault C; Institute for Immunity, Transplantation, Infections, Stanford University School of Medicine, Stanford, California, USA., Gonzalez-Kozlova E; Precision Immunology Institute and Tisch Cancer Institute, Department of Immunology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Manyam G; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chen H; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Duose DY; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Laberiano Fernandez C; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Luthra R; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Al-Atrash G; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kim-Schulze S; Icahn School of Medicine at Mount Sinai, New York, New York, USA., Maecker HT; Stanford University School of Medicine, Stanford, California, USA., Wistuba II; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gnjatic S; Medicine - Hem/Onc, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Lee JJ; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Hosuton, Texas, USA., Zhang J; Thoracic Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, UK., Magner CM; SWOG, San Antonio, Texas, USA., Chen HX; CTEP, National Cancer Institute, Bethesda, Maryland, USA., Sharon E; National Cancer Institute, Bethesda, Maryland, USA., Othus M; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Ryan CW; OHSU, Portland, Oregon, USA., Blanke C; OHSU, Portland, Oregon, USA., Haymaker CL; Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kurzrock R; Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Jun 30; Vol. 13 (6). Date of Electronic Publication: 2025 Jun 30.
Publication Type: Journal Article; Clinical Trial, Phase II
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40588371
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Patel+SP%22">Patel SP</searchLink>; UC San Diego Health Moores Cancer Center, La Jolla, California, USA spatel@ucsd.edu.<br /><searchLink fieldCode="AU" term="%22Fisher+J%22">Fisher J</searchLink>; University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Chae+YK%22">Chae YK</searchLink>; Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Soto+LS%22">Soto LS</searchLink>; Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Kasi+A%22">Kasi A</searchLink>; KUMC, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Konda+B%22">Konda B</searchLink>; Internal Medicine, Division Of Medical Oncology, The Ohio State University, Columbus, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Walshauser+M%22">Walshauser M</searchLink>; Cancer Care Center of O'Fallon, O'Fallon, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Parra+E%22">Parra E</searchLink>; Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Hosuton, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Duault+C%22">Duault C</searchLink>; Institute for Immunity, Transplantation, Infections, Stanford University School of Medicine, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Kozlova+E%22">Gonzalez-Kozlova E</searchLink>; Precision Immunology Institute and Tisch Cancer Institute, Department of Immunology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Manyam+G%22">Manyam G</searchLink>; University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Chen+H%22">Chen H</searchLink>; University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Duose+DY%22">Duose DY</searchLink>; University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Laberiano+Fernandez+C%22">Laberiano Fernandez C</searchLink>; University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Luthra+R%22">Luthra R</searchLink>; University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Al-Atrash+G%22">Al-Atrash G</searchLink>; University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Kim-Schulze+S%22">Kim-Schulze S</searchLink>; Icahn School of Medicine at Mount Sinai, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Maecker+HT%22">Maecker HT</searchLink>; Stanford University School of Medicine, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Wistuba+II%22">Wistuba II</searchLink>; University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Gnjatic+S%22">Gnjatic S</searchLink>; Medicine - Hem/Onc, Icahn School of Medicine at Mount Sinai, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Lee+JJ%22">Lee JJ</searchLink>; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Hosuton, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Thoracic Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, UK.<br /><searchLink fieldCode="AU" term="%22Magner+CM%22">Magner CM</searchLink>; SWOG, San Antonio, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Chen+HX%22">Chen HX</searchLink>; CTEP, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Sharon+E%22">Sharon E</searchLink>; National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Othus+M%22">Othus M</searchLink>; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Ryan+CW%22">Ryan CW</searchLink>; OHSU, Portland, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Blanke+C%22">Blanke C</searchLink>; OHSU, Portland, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Haymaker+CL%22">Haymaker CL</searchLink>; Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Kurzrock+R%22">Kurzrock R</searchLink>; Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2025 Jun 30; Vol. 13 (6). <i>Date of Electronic Publication: </i>2025 Jun 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40588371
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2025-011760
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Patel SP
      – PersonEntity:
          Name:
            NameFull: Fisher J
      – PersonEntity:
          Name:
            NameFull: Chae YK
      – PersonEntity:
          Name:
            NameFull: Soto LS
      – PersonEntity:
          Name:
            NameFull: Kasi A
      – PersonEntity:
          Name:
            NameFull: Konda B
      – PersonEntity:
          Name:
            NameFull: Walshauser M
      – PersonEntity:
          Name:
            NameFull: Parra E
      – PersonEntity:
          Name:
            NameFull: Zhang J
      – PersonEntity:
          Name:
            NameFull: Duault C
      – PersonEntity:
          Name:
            NameFull: Gonzalez-Kozlova E
      – PersonEntity:
          Name:
            NameFull: Manyam G
      – PersonEntity:
          Name:
            NameFull: Zhang J
      – PersonEntity:
          Name:
            NameFull: Chen H
      – PersonEntity:
          Name:
            NameFull: Duose DY
      – PersonEntity:
          Name:
            NameFull: Laberiano Fernandez C
      – PersonEntity:
          Name:
            NameFull: Luthra R
      – PersonEntity:
          Name:
            NameFull: Al-Atrash G
      – PersonEntity:
          Name:
            NameFull: Kim-Schulze S
      – PersonEntity:
          Name:
            NameFull: Maecker HT
      – PersonEntity:
          Name:
            NameFull: Wistuba II
      – PersonEntity:
          Name:
            NameFull: Gnjatic S
      – PersonEntity:
          Name:
            NameFull: Lee JJ
      – PersonEntity:
          Name:
            NameFull: Zhang J
      – PersonEntity:
          Name:
            NameFull: Magner CM
      – PersonEntity:
          Name:
            NameFull: Chen HX
      – PersonEntity:
          Name:
            NameFull: Sharon E
      – PersonEntity:
          Name:
            NameFull: Othus M
      – PersonEntity:
          Name:
            NameFull: Ryan CW
      – PersonEntity:
          Name:
            NameFull: Blanke C
      – PersonEntity:
          Name:
            NameFull: Haymaker CL
      – PersonEntity:
          Name:
            NameFull: Kurzrock R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 06
              Text: 2025 Jun 30
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1